Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Efficacy of Preoperative Immunotherapy Combined Treatment in Advanced Gastric Cancer

NCT07824479 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07824479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07824479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Efficacy of Preoperative Immunotherapy Combined Treatment in Advanced Gastric Cancer
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 17, 2025
Completion date
May 31, 2033
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastric cancer